India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide
Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Subscribe To Our Newsletter & Stay Updated